Obstructive Sleep Apnea Syndrome In Patients Treated For Cancer Of The Upper Aerodigestive Tract

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

142 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-21

Study Completion Date

2023-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective open-label, non-randomized, monocentric, cohort study, to assess the prevalence and severity of sleep apnea syndrome in patients treated for cancer of the upper aerodigestive tract.

The patient follows a usual course of care including, at the end of the treatment of his cancer of the upper aerodigestive tract, screening for obstructive sleep apnea syndrome at 3 months and 6 months (Epworth score and ventilatory polygraphy)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Obstructive Sleep Apnea Syndrome After Oropharyngeal Cancer Treatment

NCT02881723

Obstructive Sleep Apnea Syndrome Oropharyngeal Cancer

UNKNOWN NA

Obstructive Apnea in Patients Submitted to Partial Laryngectomy

NCT01157286

OBSTRUCTIVE SLEEP APNEA

UNKNOWN

Prospective Study to Evaluate Outcomes From Transoral BOT Resection for OSAHS

NCT01107795

Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)

TERMINATED

Accelerated Aging in Middle-Aged Men With Sleep-disordered Breathing.

NCT02876653

Obstructive Sleep Apnea

COMPLETED NA

Sleep Apnea in Head and Neck Cancer Patients at the University of Colorado

NCT04922112

Obstructive Sleep Apnea Squamous Cell Carcinoma of Head and Neck

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective open-label, non-randomized, monocentric, cohort study, to assess the prevalence and severity of sleep apnea syndrome in patients treated for cancer of the upper aerodigestive tract.

Patients are included in the study when they are hospitalized for panendoscopy. Thereafter, it takes about 1 month to start any treatment. The duration of treatment is estimated at about 5 months (the longest regimen would be induction chemotherapy followed by surgery and adjuvant complementary treatment). After which the patient follows a usual course of care including, at the end of the treatment of his cancer of the upper aerodigestive tract, screening for obstructive sleep apnea syndrome at 3 months and 6 months (Epworth score and ventilatory polygraphy).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Aerodigestive Tract Neoplasms Obstructive Sleep Apnea-hypopnea Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* macroscopic lesion suggestive of a cancerous tumour of the upper aerodigestive tract (oral cavity, oropharynx, larynx, hypopharynx, cavum, cervical lymph node metastases with an occult primary cancer)
* awaiting anatomopathological confirmation

Exclusion Criteria

* history of cancer of the upper aerodigestive tract
* history of known obstructive sleep apnea syndrome
* cancer of the thyroid, salivary glands, nose and paranasal sinuses
* patients under guardianship or curatorship

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No